Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 8, 2020
Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration
Lauren Matheson, Jo Nayoan, Carol Rivas, et al.
Inflammatory Bowel Diseases
|
April 23, 2016
Substitution with Alternative Anti-TNFα Therapy (SAVANT)-Outcomes of a Crohn's Disease Cohort Undergoing Substitution Therapy with Certolizumab
Moheb Boktor, Andrew Motlis, Avinash Aravantagi, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology
|
April 2, 2022
Risk Stratification in Post-ERCP Pancreatitis: How Do Procedures, Patient Characteristics and Clinical Indicators Influence Outcomes?
Kapil Kohli, Hrishikesh Samant, Kashif Khan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis
Makoto Sasaki, Sulaiman Bharwani, Paul Jordan, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
November 12, 2015
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management
Pegah Hosseini-Carroll, Monica Mutyala, Abhishek Seth, et al.
World Journal of Gastroenterology
|
July 14, 2015
Gastric cancer in women: A regional health-center seven year retrospective study
Kunal Suryawala, Demiana Soliman, Monica Mutyala, et al.
Inflammatory Bowel Diseases
|
November 11, 2009
Angiopoietin-2 in experimental colitis
Vijay C Ganta, Walter Cromer, Ginny L Mills, et al.
British Journal of Clinical Pharmacology
|
October 11, 2018
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
Stefan Sturm, Andreas Günther, Birgit Jaber, et al.
Cell
|
September 10, 2019
Structure of the Respiratory Syncytial Virus Polymerase Complex
Morgan S A Gilman, Cheng Liu, Amy Fung, et al.
The Lancet. Diabetes & Endocrinology
|
May 6, 2014
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Norbert Stefan, Markus Ramsauer, Paul Jordan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 8, 2020
Strategies for living well with hormone-responsive advanced prostate cancer-a qualitative exploration
Lauren Matheson, Jo Nayoan, Carol Rivas, et al.
Inflammatory Bowel Diseases
|
April 23, 2016
Substitution with Alternative Anti-TNFα Therapy (SAVANT)-Outcomes of a Crohn's Disease Cohort Undergoing Substitution Therapy with Certolizumab
Moheb Boktor, Andrew Motlis, Avinash Aravantagi, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology
|
April 2, 2022
Risk Stratification in Post-ERCP Pancreatitis: How Do Procedures, Patient Characteristics and Clinical Indicators Influence Outcomes?
Kapil Kohli, Hrishikesh Samant, Kashif Khan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis
Makoto Sasaki, Sulaiman Bharwani, Paul Jordan, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
November 12, 2015
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management
Pegah Hosseini-Carroll, Monica Mutyala, Abhishek Seth, et al.
World Journal of Gastroenterology
|
July 14, 2015
Gastric cancer in women: A regional health-center seven year retrospective study
Kunal Suryawala, Demiana Soliman, Monica Mutyala, et al.
Inflammatory Bowel Diseases
|
November 11, 2009
Angiopoietin-2 in experimental colitis
Vijay C Ganta, Walter Cromer, Ginny L Mills, et al.
British Journal of Clinical Pharmacology
|
October 11, 2018
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
Stefan Sturm, Andreas Günther, Birgit Jaber, et al.
Cell
|
September 10, 2019
Structure of the Respiratory Syncytial Virus Polymerase Complex
Morgan S A Gilman, Cheng Liu, Amy Fung, et al.
The Lancet. Diabetes & Endocrinology
|
May 6, 2014
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Norbert Stefan, Markus Ramsauer, Paul Jordan, et al.
Page
of 6